Drug‐induced ubiquitylation and degradation of ErbB receptor tyrosine kinases: implications for cancer therapy
Open Access
- 15 May 2002
- journal article
- Published by Springer Nature in The EMBO Journal
- Vol. 21 (10) , 2407-2417
Abstract
EMBO Press is an editorially independent publishing platform for the development of EMBO scientific publications.Keywords
This publication has 31 references indexed in Scilit:
- Hsp90, not Grp94, regulates the intracellular trafficking and stability of nascent ErbB2Cell Stress and Chaperones, 2002
- Diversification of Neu differentiation factor and epidermal growth factor signaling by combinatorial receptor interactions.The EMBO Journal, 1996
- p185erbB2 Binds to GRP94 in VivoJournal of Biological Chemistry, 1996
- Disruption of the Raf-1-Hsp90 Molecular Complex Results in Destabilization of Raf-1 and Loss of Raf-1-Ras AssociationJournal of Biological Chemistry, 1995
- Herbimycin A Induces the 20 S Proteasome- and Ubiquitin-dependent Degradation of Receptor Tyrosine KinasesJournal of Biological Chemistry, 1995
- Intracellular expression of single chain antibodies reverts ErbB-2 transformation.Journal of Biological Chemistry, 1994
- Accelerated degradation of 160 kDa epidermal growth factor (EGF) receptor precursor by the tyrosine kinase inhibitor herbimycin A in the endoplasmic reticulum of A431 human epidermoid carcinoma cellsBiochemical Journal, 1994
- Differential heat stress stability of epidermal growth factor receptor and erbB‐2 receptor tyrosine kinase activitiesJournal of Cellular Physiology, 1993
- Therapy of an animal model of human gastric cancer using a combination of anti-erbB-2 monoclonal antibodies.1992
- Studies of the HER-2/ neu Proto-Oncogene in Human Breast and Ovarian CancerScience, 1989